Join
Live feed
·
PRReleasevia Quantisnow
Alvotech logo

Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®

ByQuantisnow·Wall Street's wire, on your screen.
ALVO· Alvotech
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALVO (Alvotech) and more on Quantisnow.